Raymond James analyst Brian Peterson downgrades UserTesting (NYSE:USER) from Strong Buy to Market Perform.
The Latest Analyst Ratings for Unity Biotechnology
Within the last quarter, Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…